CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
84 hedge funds and large institutions have $1.29B invested in China Biologic Products Holdings, Inc. in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 28 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-3
Holders Change %
-3.45%
% of All Funds
1.86%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.15%
New
16
Increased
26
Reduced
28
Closed
18
Calls
$29.8M
Puts
$6.06M
Net Calls
+$23.8M
Net Calls Change
+$6.54M
Top Buyers
| 1 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
+$44M |
| 2 |
MCP
Maso Capital Partners
Hong Kong
|
+$41.9M |
| 3 |
Renaissance Technologies
New York
|
+$22.2M |
| 4 |
Millennium Management
New York
|
+$13.7M |
| 5 |
BP
BFAM Partners
Northpoint, Hong Kong,
Hong Kong
|
+$13.7M |
Top Sellers
| 1 |
YCMGA
York Capital Management Global Advisors
New York
|
-$27.1M |
| 2 |
AII
AGF Investments Inc
Toronto,
Ontario, Canada
|
-$23.1M |
| 3 |
Man Group
London,
United Kingdom
|
-$15.3M |
| 4 |
Goldman Sachs
New York
|
-$9.58M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$4.14M |
